Saltar al contenido
Fuerza y músculoArtículo de investigación3 min read

GlyNAC supplement in 8 older adults: many aging markers improved, then faded after stopping

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial. · Clinical and translational medicine · 2021 · Artículo original ↗

Idea principal

In an open-label pilot of eight older adults, 24 weeks of GlyNAC (glycine plus N-acetylcysteine) corrected glutathione deficiency and improved markers of oxidative stress, inflammation, strength, gait speed and cognition, with benefits declining after 12 weeks off the supplement. With eight people, no placebo group and no numbers in the abstract, this is a hypothesis for larger trials rather than evidence of benefit.

Study design

Artículo de investigación

Reading basis

Published abstract

Reading focus

Design & applicability

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Oxidative stress and mitochondrial dysfunction are thought to contribute to aging, and older adults often show inflammation, insulin resistance, weak muscles and cognitive decline, with few treatments. The authors had earlier found that GlyNAC improved glutathione deficiency and related problems in aged mice, and here tested its effects and withdrawal in older people.

Población y método

36-week open-label pilot trial in eight older adults (OAs) and eight young adults (YAs). After a baseline study, the young adults left the trial. Older adults were studied again after 24 weeks of GlyNAC supplementation and after 12 weeks of withdrawal. Measurements included red-blood cell glutathione (GSH) and mitochondrial fuel oxidation, plasma markers of oxidative stress, inflammation, endothelial function, glucose and insulin, gait speed, grip strength, the 6-min walk test, cognitive tests, genomic damage, glucose production and muscle-protein breakdown rates, and body composition.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    After 24 weeks of GlyNAC, older adults had corrected red-blood cell GSH deficiency, oxidative stress and mitochondrial dysfunction.
  2. 2
    Inflammation, endothelial dysfunction, insulin resistance, genomic damage, cognition, strength, gait speed and exercise capacity improved, and body fat and waist circumference were lower.
  3. 3
    Benefits declined after GlyNAC was stopped for 12 weeks.
  4. 4
    The abstract states the supplement was well tolerated but gives no effect sizes, confidence intervals or P values.

Límites e incertidumbre

  1. 1
    Only eight older adults, so any estimate is imprecise.
  2. 2
    Open-label with no placebo group, so expectations and natural variation could contribute to changes, particularly in strength and cognition.
  3. 3
    The abstract reports no numbers, so the size and statistical strength of each change cannot be judged.
  4. 4
    This reading is based on the abstract only.

Relevancia práctica

This small trial suggests GlyNAC is worth testing in larger, placebo-controlled studies. It does not show that taking it improves health or slows aging. Whether to take any supplement, especially with medications or health conditions, is a decision for you and your clinician.

Tus datos

Related personal measures include grip strength, walking speed, a timed walk, weight, waist circumference and fasting glucose from a meter or CGM. Compare them with your own earlier values using the same method and conditions, and do not read changes as proof that a supplement worked.

Cómo interpretar la evidencia

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Background

Oxidative stress (OxS) and mitochondrial dysfunction are implicated as causative factors for aging. Older adults (OAs) have an increased prevalence of elevated OxS, impaired mitochondrial fuel-oxidation (MFO), elevated inflammation, endothelial dysfunction, insulin resistance, cognitive decline, muscle weakness, and sarcopenia, but contributing mechanisms are unknown, and interventions are limited/lacking. We previously reported that inducing deficiency of the antioxidant tripeptide glutathione (GSH) in young mice results in mitochondrial dysfunction, and that supplementing GlyNAC (combination of glycine and N-acetylcysteine [NAC]) in aged mice improves naturally-occurring GSH deficiency, mitochondrial impairment, OxS, and insulin resistance. This pilot trial in OA was conducted to test the effect of GlyNAC supplementation and withdrawal on intracellular GSH concentrations, OxS, MFO, inflammation, endothelial function, genotoxicity, muscle and glucose metabolism, body composition, strength, and cognition.

Methods

A 36-week open-label clinical trial was conducted in eight OAs and eight young adults (YAs). After all the participants underwent an initial (pre-supplementation) study, the YAs were released from the study. OAs were studied again after GlyNAC supplementation for 24 weeks, and GlyNAC withdrawal for 12 weeks. Measurements included red-blood cell (RBC) GSH, MFO; plasma biomarkers of OxS, inflammation, endothelial function, glucose, and insulin; gait-speed, grip-strength, 6-min walk test; cognitive tests; genomic-damage; glucose-production and muscle-protein breakdown rates; and body-composition.

Results

GlyNAC supplementation for 24 weeks in OA corrected RBC-GSH deficiency, OxS, and mitochondrial dysfunction; and improved inflammation, endothelial dysfunction, insulin-resistance, genomic-damage, cognition, strength, gait-speed, and exercise capacity; and lowered body-fat and waist-circumference. However, benefits declined after stopping GlyNAC supplementation for 12 weeks.

Conclusions

GlyNAC supplementation for 24-weeks in OA was well tolerated and lowered OxS, corrected intracellular GSH deficiency and mitochondrial dysfunction, decreased inflammation, insulin-resistance and endothelial dysfunction, and genomic-damage, and improved strength, gait-speed, cognition, and body composition. Supplementing GlyNAC in aging humans could be a simple and viable method to promote health and warrants additional investigation.

Fuentes y atribución

Glycine and N-acetylcysteine (GlyNAC) supplementation in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, and cognition: Results of a pilot clinical trial.

Kumar P, Liu C, Hsu JW, Chacko S, Minard C, Jahoor F, Sekhar RV.

Clinical and translational medicine · 2021-03-01

DOI: 10.1002/ctm2.372 ↗PubMed · 33783984 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Revisión de revisiones

ACSM review of 137 reviews: resistance training works, and few programme details matter

The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.

Medicine & Science in Sports & Exercise

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Nearly every resistance training plan beat no exercise; heavy loads led for strength

In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
·Metaanálisis observacional

Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes

Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Protein supplements and weight training: small extra gains, smaller in older adults

Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
Fuerza y músculo →